Nootropil 800 mg: Enhance Cognitive Function and Memory Support
| Product dosage: 800mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.11 | $66.34 (0%) | 🛒 Add to cart |
| 90 | $1.07 | $99.51 $96.50 (3%) | 🛒 Add to cart |
| 120 | $1.05 | $132.68 $125.65 (5%) | 🛒 Add to cart |
| 180 | $1.03 | $199.02 $184.95 (7%) | 🛒 Add to cart |
| 270 | $1.02 | $298.54 $274.41 (8%) | 🛒 Add to cart |
| 360 | $1.01
Best per pill | $398.05 $364.88 (8%) | 🛒 Add to cart |
Synonyms
| |||
Nootropil 800 mg contains the active substance piracetam, a nootropic agent belonging to the racetam class. It is primarily indicated for the management of cortical myoclonus, though it is also widely recognized for its off-label use in supporting cognitive function, particularly in contexts involving memory and mental clarity. This medication works by modulating neurotransmission, improving neuronal plasticity, and enhancing microcirculation in the brain. Available in 800 mg tablet form, it requires a prescription in many regions and should be used under strict medical supervision to ensure safety and efficacy.
Features
- Active ingredient: Piracetam 800 mg per tablet
- Pharmaceutical form: Film-coated tablet
- Mechanism of action: Modulates glutamate and acetylcholine receptors; enhances neuronal membrane fluidity
- Prescription status: Available by prescription in most countries
- Manufacturer specifications: Produced under GMP standards; typically packaged in blisters of 10 or 20 tablets
Benefits
- Supports improvement in learning capacity and memory recall
- May aid in the management of cortical myoclonus, reducing involuntary muscle jerks
- Enhances cognitive performance under conditions of hypoxia or oxidative stress
- Promotes interhemispheric communication and synaptic neurotransmission
- Can contribute to better focus and mental energy in appropriate clinical contexts
- Supports neuronal recovery and protection in certain neurological conditions
Common use
Nootropil (piracetam) is officially approved for the treatment of cortical myoclonus, a condition characterized by sudden, involuntary muscle contractions originating from the cerebral cortex. Off-label, it is frequently used to support cognitive function in cases of age-related memory decline, post-stroke recovery, dyslexia, and vertigo of central origin. Its application in cognitive enhancement is supported by its ability to improve neuronal metabolism and facilitate communication between brain hemispheres.
Dosage and direction
The dosage of Nootropil must be individualized based on the condition being treated, patient response, and medical guidance. For cortical myoclonus, initial doses often start at 7.2 g/day, divided into 2–3 doses, with maintenance doses adjusted accordingly. When used for cognitive support, typical off-label doses range from 2.4 g to 4.8 g daily, divided into 2–3 administrations. Tablets should be swallowed whole with water, preferably with meals to minimize potential gastrointestinal discomfort. Dosage titration and long-term use should be supervised by a healthcare professional.
Precautions
Patients with a history of bleeding disorders or those undergoing surgery should use Nootropil with caution due to its potential effects on platelet aggregation. Renal impairment requires dosage adjustment or avoidance, as piracetam is excreted renally. Use in elderly patients should involve careful monitoring of renal function. Discontinuation should be gradual if used long-term to avoid withdrawal effects. It is not recommended during pregnancy or breastfeeding unless explicitly advised by a physician.
Contraindications
Nootropil is contraindicated in patients with known hypersensitivity to piracetam or any excipients in the formulation. It should not be used in those with severe renal impairment (creatinine clearance <20 mL/min) or hepatic failure. Contraindications also include patients with cerebral hemorrhage and Huntington’s chorea, due to insufficient safety data and potential exacerbation of symptoms.
Possible side effects
Common side effects may include nervousness, weight gain, drowsiness, depression, and gastrointestinal symptoms such as nausea, vomiting, or diarrhea. Less frequently, hyperkinesia, rash, or dizziness have been reported. In rare cases, piracetam may cause severe effects such as thrombophlebitis, angioedema, or confusion. Patients should seek medical attention if side effects persist or worsen.
Drug interactions
Nootropil may interact with thyroid hormone medications, potentially necessitating adjustment. It can enhance the effects of anticoagulants like warfarin, increasing bleeding risk. Concomitant use with other CNS-acting drugs, including antidepressants and antipsychotics, may lead to additive sedative or stimulatory effects. Always inform your healthcare provider of all medications, supplements, or herbal products you are taking.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to catch up. Maintaining a consistent dosing schedule is important for stable plasma levels, especially in the management of myoclonus.
Overdose
Symptoms of overdose may include diarrhea, abdominal pain, and pronounced lethargy. In severe cases, neurological symptoms such as agitation or confusion may occur. There is no specific antidote; treatment is supportive and symptomatic. Gastric lavage or activated charcoal may be considered if ingestion was recent. Immediate medical attention is required.
Storage
Store at room temperature (15–30°C), in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment choices, and personalized dosage recommendations. Do not initiate, adjust, or discontinue medication without medical supervision.
Reviews
Clinical studies and patient reports often highlight Nootropil’s efficacy in reducing myoclonic jerks and supporting cognitive metrics such as memory and attention in vulnerable populations. However, experiences vary, and evidence for use in healthy individuals remains debated. Long-term safety and effect sustainability require further research. Always rely on evidence-based guidance when considering this medication.